Shareholder alert: pomerantz law firm investigates claims on behalf of investors of arbutus biopharma corporation - abus

New york , april 26, 2023 /prnewswire/ -- pomerantz llp is investigating claims on behalf of investors of arbutus biopharma corporation ("arbutus" or the "company") (nasdaq: abus). such investors are advised to contact robert s.

ABUS Ratings Summary

ABUS Quant Ranking